The Technology Information, Forecasting and Assessment Council (TIFAC) has recently released a report on ‘Active Pharmaceutical Ingredients’ (API).
Along with the report, a white paper titled ‘Focused Interventions for Make in India : Post COVID 19’ was also released
The pharmaceutical industry in India is third largest in the world, in terms of volume, behind China and Italy, and fourteenth largest in terms of value.
Active Pharmaceutical Ingredient (API) is a substance or mixture of substances contained in a medicine that is intended to cause pharmacological activity.
TIFAC is an autonomous body under the Department of Science and Technology.